Table I.
Clinical information regarding hepatocellular carcinoma samples.
| Characteristic | Number of cases (%) |
|---|---|
| Total | 80 (100) |
| Gender | |
| Male | 68 (85) |
| Female | 12 (15) |
| Age (years) | |
| <50 | 34 (42.5) |
| ≥50 | 46 (57.5) |
| Size (cm) | |
| ≤2, no invasion | 0 (0) |
| ≤5, or 3 nodules, ≤3; no invasion | 11 (13.75) |
| >5, or multiple nodules | 15 (18.75) |
| Vascular invasion | 54 (67.5) |
| Vascular invasion | |
| Negative | 26 (32.5) |
| Position | 54 (67.5) |
| Number of tumors | |
| 1 | 62 (77.5) |
| ≥2 | 18 (22.5) |
| Liver cirrhosis | |
| Negative | 6 (7.5) |
| Positive | 74 (92.5) |
| Child-Pugh grade | |
| A | 74 (92.5) |
| B | 6 (7.5) |
| C | 0 (0) |
| HBsAg | |
| Negative | 21 (26.25) |
| Positive | 59 (73.75) |
| AFP (ng/ml) | |
| ≤20 | 29 (36.25) |
| >20 | 51 (63.75) |
| Tumor histological grade | |
| I | 3 (3.75) |
| I–II | 8 (10) |
| II | 44 (55) |
| II–III | 7 (8.75) |
| III | 18 (22.5) |
| TNM classification | |
| 1 (TIN0M0) | 25 (31.25) |
| 2 (T2N0M0) | 34 (42.5) |
| 3 (T2N1M0 or T3N0M0) | 21 (25) |
HBsAg, hepatitis B surface antigen; AFP, alpha fetal protein; TNM, tumor node metastasis.